These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38745011)

  • 21. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia.
    Kurnellas M; Mitra A; Schwabe T; Paul R; Arrant AE; Roberson ED; Ward M; Yeh F; Long H; Rosenthal A
    J Transl Med; 2023 Jun; 21(1):387. PubMed ID: 37322482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by
    Holler CJ; Taylor G; Deng Q; Kukar T
    eNeuro; 2017; 4(4):. PubMed ID: 28828399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation.
    Alberici A; Archetti S; Pilotto A; Premi E; Cosseddu M; Bianchetti A; Semeraro F; Salvetti M; Muiesan ML; Padovani A; Borroni B
    Neurol Sci; 2014 Aug; 35(8):1215-9. PubMed ID: 24569924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice.
    Zhou X; Brooks M; Jiang P; Koga S; Zuberi AR; Baker MC; Parsons TM; Castanedes-Casey M; Phillips V; Librero AL; Kurti A; Fryer JD; Bu G; Lutz C; Dickson DW; Rademakers R
    EMBO Rep; 2020 Oct; 21(10):e50197. PubMed ID: 32761777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
    Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
    Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.
    Chitramuthu BP; Bennett HPJ; Bateman A
    Brain; 2017 Dec; 140(12):3081-3104. PubMed ID: 29053785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in Lysosomal, Glial and Neurodegenerative Biomarkers in Patients with Sporadic and Genetic Forms of Frontotemporal Dementia.
    Hsiao-Nakamoto J; Chiu CL; VandeVrede L; Ravi R; Vandenberg B; De Groot J; Tsogtbaatar B; Fang M; Auger P; Gould NS; Marchioni F; Powers CA; Davis SS; Suh JH; Alkabsh J; Heuer HW; Lago AL; Scearce-Levie K; Seeley WW; Boeve BF; Rosen HJ; Berger A; Tsai R; Di Paolo G; Boxer AL; Bhalla A; Huang F;
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Wilke C; Gillardon F; Deuschle C; Dubois E; Hobert MA; Müller vom Hagen J; Krüger S; Biskup S; Blauwendraat C; Hruscha M; Kaeser SA; Heutink P; Maetzler W; Synofzik M
    Curr Alzheimer Res; 2016; 13(6):654-62. PubMed ID: 26971930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
    Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
    Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
    Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration.
    Wauters E; Gossye H; Frydas A; Sieben A; Van Broeckhoven C
    Neurobiol Aging; 2023 Oct; 130():61-69. PubMed ID: 37459659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients.
    Almeida S; Gao F; Coppola G; Gao FB
    Neurobiol Aging; 2016 Jun; 42():35-40. PubMed ID: 27143419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of extracellular vesicles in progranulin-deficient mice and FTD-GRN Patients.
    Arrant AE; Davis SE; Vollmer RM; Murchison CF; Mobley JA; Nana AL; Spina S; Grinberg LT; Karydas AM; Miller BL; Seeley WW; Roberson ED
    Ann Clin Transl Neurol; 2020 Dec; 7(12):2433-2449. PubMed ID: 33197149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core features of frontotemporal dementia recapitulated in progranulin knockout mice.
    Ghoshal N; Dearborn JT; Wozniak DF; Cairns NJ
    Neurobiol Dis; 2012 Jan; 45(1):395-408. PubMed ID: 21933710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
    Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
    J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration.
    Goossens J; Bjerke M; Van Mossevelde S; Van den Bossche T; Goeman J; De Vil B; Sieben A; Martin JJ; Cras P; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
    Alzheimers Res Ther; 2018 Mar; 10(1):31. PubMed ID: 29559004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling the cascade of biomarker changes in
    Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; Meeter LHH; Donker Kaat L; Rombouts SARB; Vernooij MW; Kievit AJA; Premi E; Cosseddu M; Bonomi E; Olives J; Rohrer JD; Sánchez-Valle R; Borroni B; Bron EE; Van Swieten JC; Papma JM; Klein S;
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):494-501. PubMed ID: 33452053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.